GGrantIndex
← Leaderboards

Ricardo Otazo

New York University School Of Medicine

Google Scholar ↗PubMed ↗ORCID ↗
$7,314,631
Attributed
$10,173,417
Total exposure
4
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.3M · FY2014–25
$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,173,417 · 4

By mechanism

R01$6,197,711 · 2
U01$2,843,782 · 1
P41$1,131,924 · 1

Top collaborators

Most similar at New York University School Of Medicine

Same institution · by research overlap

Others in their field

Top investigators on “Magnetic Resonance Imaging”

Research focus

Magnetic Resonance ImagingImageReconstructionBreathingRadialMotionTechnologyBaseAreaPerformanceScanningReproducibilityGenerationsConvolutional Neural NetworkLearningDimensionsMalignant NeoplasmsTumorDeep LearningAffectImaging ModalityClinical PracticeMapsDatabases

Grant awards (19)

Real-time MRI-guided adaptive radiotherapy of unresectable pancreatic cancer$683,094
R01 · FY2025 · CA · contact PI
Real-time MRI-guided adaptive radiotherapy of unresectable pancreatic cancer$660,804
R01 · FY2024 · CA · contact PI
Rapid motion-robust quantitative DCE-MRI for the assessment of gynecologic cancers$549,623
R01 · FY2024 · CA · contact PI
Real-time MRI-guided adaptive radiotherapy of unresectable pancreatic cancer$687,789
R01 · FY2023 · CA · contact PI
Rapid motion-robust quantitative DCE-MRI for the assessment of gynecologic cancers$629,001
R01 · FY2023 · CA · contact PI
Real-time MRI-guided adaptive radiotherapy of unresectable pancreatic cancer$652,055
R01 · FY2022 · CA · contact PI
Rapid motion-robust quantitative DCE-MRI for the assessment of gynecologic cancers$591,847
R01 · FY2022 · CA · contact PI
Real-time MRI-guided adaptive radiotherapy of unresectable pancreatic cancer$640,178
R01 · FY2021 · CA · contact PI
Rapid motion-robust quantitative DCE-MRI for the assessment of gynecologic cancers$568,123
R01 · FY2021 · CA · contact PI
Rapid motion-robust quantitative DCE-MRI for the assessment of gynecologic cancers$535,197
R01 · FY2020 · CA · contact PI
SparseCT: Order-of-Magnitude Dose Reduction with Interrupted-Beam Acquisition$688,448
U01 · FY2018 · EB
CAI2R Technology Research and Development Project #1: Towards Rapid Continuous Comprehensive MR Imaging: New Methods, New Paradigms, and New Applications$202,836
P41 · FY2018 · EB · contact PI
SparseCT: Order-of-Magnitude Dose Reduction with Interrupted-Beam Acquisition$698,341
U01 · FY2017 · EB
CAI2R Technology Research and Development Project #1: Towards Rapid Continuous Comprehensive MR Imaging: New Methods, New Paradigms, and New Applications$202,836
P41 · FY2017 · EB · contact PI
SparseCT: Order-of-Magnitude Dose Reduction with Interrupted-Beam Acquisition$708,158
U01 · FY2016 · EB · contact PI
CAI2R Technology Research and Development Project #1: Towards Rapid Continuous Comprehensive MR Imaging: New Methods, New Paradigms, and New Applications$202,836
P41 · FY2016 · EB · contact PI
SparseCT: Order-of-Magnitude Dose Reduction with Interrupted-Beam Acquisition$748,835
U01 · FY2015 · EB · contact PI
CAI2R Technology Research and Development Project #1: Towards Rapid Continuous Comprehensive MR Imaging: New Methods, New Paradigms, and New Applications$198,780
P41 · FY2015 · EB · contact PI
CAI2R Technology Research and Development Project #1: Towards Rapid Continuous Comprehensive MR Imaging: New Methods, New Paradigms, and New Applications$324,636
P41 · FY2014 · EB · contact PI